Arthrosi Therapeutics announced it raised $7 Million in an initial filing from an offering of $75 Million
Arthrosi Therapeutics announced it raised $7 Million in an initial filing from an offering of $75 Million
01/26/24, 6:06 PM
Location
Money raised
$7 million
Industry
healthcare
Company Info
Location
23052 alcalde drive, suite a
laguna hills, california, united states
Additional Info
Arthrosi Therapeutics is a clinical-stage biotech company focused on the development of therapy for gout and chronic kidney disease. Its proprietary drug candidate, AR882, demonstrated unprecedent sustained urate lowering in gout patients and showed potential to treat a variety of renal impaired patients suffering from gout and tophaceous gout.